Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
0 hedge funds and large institutions have $0 invested in Alimera Sciences in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 52 closing their positions.
100% less funds holding
Funds holding: 52 → 0 (-52)
100% less funds holding in top 10
Funds holding in top 10: 4 → 0 (-4)
100% less capital invested
Capital invested by funds: $258M → $0 (-$258M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 52
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CP
Caligan Partners
New York
|
-$93.6M |
| 2 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
-$75.7M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$19.5M |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$17.8M |
| 5 |
ACM
Altium Capital Management
New York
|
-$12M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
Comerica Bank
Dallas,
Texas
| – | -$78 | -14 | Closed |
|
|
NA
52
NewEdge Advisors
New Orleans,
Louisiana
| – | -$12 | -2 | Closed |
|
ALIM Hedge Fund Activity: Q3 2024 in Review
0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q3 2024, worth a combined $0 — down 100% from $258M a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of ALIM and 0 opened new positions — a net loss of 52 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Caligan Partners, exiting entirely with an estimated $93.6M sold.
- 0 institutional investors held Alimera Sciences (ALIM) as of Q3 2024, down from 52 in Q2 2024.
- Funds reported $0 of Alimera Sciences stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Alimera Sciences positions in Q3 2024 and 52 closed out, a net change of -52 holders.
- The largest Alimera Sciences seller in Q3 2024 was Caligan Partners, an estimated $93.6M sold.
Based on aggregated 13F filings for Q3 2024.